Cargando…
Stereotactic body radiotherapy for early stage non-small cell lung cancer in patients with subclinical interstitial lung disease
BACKGROUND: For lung cancer patients with subclinical (untreated and asymptomatic) interstitial lung disease (ILD), there is a lack of relatively safe and effective treatment. Stereotactic body radiation therapy (SBRT) can achieve a high level of tumor control with low toxicity in early-stage non-sm...
Autores principales: | Liu, Yuanjun, Zhu, Yaoyao, Wu, Ran, Hu, Min, Zhang, Lingnan, Lin, Qingren, Weng, Denghu, Sun, Xiaojiang, Liu, Yu, Xu, Yaping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815350/ https://www.ncbi.nlm.nih.gov/pubmed/33489796 http://dx.doi.org/10.21037/tlcr-20-1050 |
Ejemplares similares
-
The CT appearance pattern of radiation-induced lung injury and tumor recurrence after stereotactic body radiation therapy in early stage non-small cell lung cancer
por: Li, Qian, et al.
Publicado: (2020) -
Four-year follow-up outcomes after stereotactic body radiation therapy for central early-stage non-small cell lung cancer
por: Sun, Xiaojiang, et al.
Publicado: (2020) -
Outcomes of stereotactic body radiotherapy versus lobectomy for stage I non-small cell lung cancer: a propensity score matching analysis
por: Lin, Qingren, et al.
Publicado: (2019) -
A Propensity-Matched Analysis of Survival of Clinically Diagnosed Early-Stage Lung Cancer and Biopsy-Proven Early-Stage Non-Small Cell Lung Cancer Following Stereotactic Ablative Radiotherapy
por: Zhang, Ran, et al.
Publicado: (2021) -
Analysis of Clinical and Dosimetric Factors Influencing Radiation-Induced Lung Injury in Patients with Lung Cancer
por: Han, Shuiyun, et al.
Publicado: (2015)